Abstract:Background Bromodomain is an evolutionally conserved domain that is found in proteins strongly implicated in signal-dependent transcriptional regulation. Genetic alterations of bromodomain genes contributed to the development of many human cancers and other disorders. BRD7 is a recently identified bromodomain gene. It plays a critical role in cellular growth, cell cycle progression, and signal-dependent gene expression. Previous studies showed that BRD7 gene exhibited much higher-level of mRNA expression in normal nasopharyngeal epithelia than in nasopharyngeal carcinoma (NPC) biopsies and cell lines. However, little is known about its transcriptional regulation. In this study, we explored the transcriptional regulation of BRD7 gene. Method Potential binding sites of transcription factors within the promoter region of BRD7 gene were predicted with MatInspector Professional http://genomatix.de/cgi-bin/matinspector_prof/mat_fam.pl . Mutation construct methods and luciferase assays were performed to define the minimal promoter of BRD7 gene. RT-PCR and western blot assays were used to detect the endogenous expression of transcription factor Sp1, c-Myc and E2F6 in all cell lines used in this study. Electrophoretic mobility shift assays (EMSA) and Chromatin immunoprecipitation (ChIP) were used to detect the direct transcription factors that are responsible for the promoter activity of BRD7 gene. DNA vector-based siRNA technology and cell transfection methods were employed to establish clone pools that stably expresses SiRNA against c-Myc expression in nasopharyngeal carcinoma 5-8F cells. Real-time PCR was used to detect mRNA expression of BRD7 gene in 5-8F/Si-c-Myc cells. Results We defined the minimal promoter of BRD7 gene in a 55-bp region (from -266 to -212bp), and identified that its promoter activity is inversely related to c-Myc expression. Sp1 binds to the Sp1/Myc-Max overlapping site of BRD7 minimal promoter, and slightly positively regulate its promoter activity. c-Myc binds to this Sp1/Myc-Max overlapping site as well, and negatively regulates the promoter activity and endogenous mRNA expression of BRD7 gene. Knock-down of c-Myc increases the promoter activity and mRNA level of BRD7 gene. The luciferase activity of the mutated promoter constructs showed that Sp1/Myc-Max overlapping site is a positive regulation element of BRD7 promoter. Conclusion These studies provide for the first time the evidence that c-Myc is indeed a negative regulator of BRD7 gene. These findings will help to further understand and uncover the bio-functions of BRD7 gene involved in the pathogenesis of NPC.

BRD7 Expression and C-Myc Activation Forms a Double-Negative Feedback Loop That Controls the Cell Proliferation and Tumor Growth of Nasopharyngeal Carcinoma by Targeting Oncogenic Mir-141

miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma

BRD7 Inhibits Enhancer Activity and Expression of BIRC2 to Suppress Tumor Growth and Metastasis in Nasopharyngeal Carcinoma

Microrna-141 is Involved in a Nasopharyngeal Carcinoma-Related Genes Network.

CircBRD7 inhibits tumor growth and metastasis in nasopharyngeal carcinoma via forming a positive feedback regulation loop with its host gene

Transcriptional regulation of BRD7 expression by Sp1 and c-Myc

CircBRD7 Attenuates Tumor Growth and Metastasis in Nasopharyngeal Carcinoma Via Epigenetic Activation of Its Host Gene.

BRD7 Suppresses the Growth of Nasopharyngeal Carcinoma Cells (HNE1) Through Negatively Regulating Β-Catenin and ERK Pathways

Promoter Methylation Inhibits BRD7 Expression in Human Nasopharyngeal Carcinoma Cells

Knockdown of C-Myc Inhibits Cell Proliferation by Negatively Regulating the Cdk/Rb/E2F Pathway in Nasopharyngeal Carcinoma Cells

Zinc-finger Protein YY1 Suppresses Tumor Growth of Human Nasopharyngeal Carcinoma by Inactivating C-Myc–mediated Microrna-141 Transcription

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma

MiR-138 Suppressed Nasopharyngeal Carcinoma Growth and Tumorigenesis by Targeting the CCND1 Oncogene

Identification of Mir-143 As A Tumour Suppressor in Nasopharyngeal Carcinoma Based on Microrna Expression Profiling

MiR-663, a Microrna Targeting P21waf1/cip1, Promotes the Proliferation and Tumorigenesis of Nasopharyngeal Carcinoma

Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation

Mir-181A Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP

Mir-9 Targets CXCR4 and Functions As a Potential Tumor Suppressor in Nasopharyngeal Carcinoma.

c‐Myc‐induced circ‐NOTCH1 promotes aggressive phenotypes of nasopharyngeal carcinoma cells by regulating the miR‐34c‐5p/c‐Myc axis

MicroRNA‑342‑3p Suppresses Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Directly Targeting Cdc42

Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A.